human ovarian cancer cell line skov3 (ATCC)
Structured Review

Human Ovarian Cancer Cell Line Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 7638 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ovarian+cancer+cell+line/SK-OV-3/pmc13084341-20-13-22
Average 99 stars, based on 7638 article reviews
Images
1) Product Images from "Blockade of co-inhibitory receptor immune checkpoint protein TIM3/CD366 augments the anti-cancer activity of CAR-T therapy in solid tumors: An ovarian cancer example"
Article Title: Blockade of co-inhibitory receptor immune checkpoint protein TIM3/CD366 augments the anti-cancer activity of CAR-T therapy in solid tumors: An ovarian cancer example
Journal: Genes & Diseases
doi: 10.1016/j.gendis.2025.101978
Figure Legend Snippet: Specific IFN-γ and TNF-α release of T lymphocytes transduced with TIM-3-silenced HER2-specific chimeric antigen receptor (CAR) or HER2-specific CAR. (A, B) TIM-3-silenced CAR-T cells and control T cells were co-incubated with Galectin-9 + or Galectin-9 – SKOV3 tumor cells (E:T ratio 5:1 or 10:1). At 20 h after coculture, a specific enzyme-linked immunosorbent assay was used to analyze the supernatant for IFN-γ cytokine-release. Results were presented as mean ± standard deviation. (C, D) The detection of TNF-α in the same culture supernatant. Results were presented as mean ± standard deviation. ∗ P < 0.05 and ∗∗ P < 0.01.
Techniques Used: Transduction, Control, Incubation, Enzyme-linked Immunosorbent Assay, Standard Deviation
Figure Legend Snippet: TIM-3 silencing augmented the anti-tumor activity of chimeric antigen receptor-T (CAR-T) cells in vivo . 2 × 10 6 SKOV3 tumor cells expressing luciferase were intraperitoneally inoculated in a xenograft mouse model, and 7 days after inoculation, the 2 × 10 6 HER2-specific CAR-T kdTim-3 cells or CAR-T cells, or untreated T cells were intraperitoneally administered. (A, B) Tumor growth was monitored using an in vivo imaging system. (C) Survival curve of 80-day post-treatment. ∗ P < 0.05 and ∗∗ P < 0.01.
Techniques Used: Activity Assay, In Vivo, Expressing, Luciferase, In Vivo Imaging
Related Articles
other:Article Title: Targeted paclitaxel delivery in ovarian cancer via AP1-functionalized elastin-like polypeptide nanocarriers: development and characterization. Article Snippet: The Article Title: Targeted paclitaxel delivery in ovarian cancer via AP1-functionalized elastin-like polypeptide nanocarriers: development and characterization Article Snippet: The Article Title: Precise detection of differential RNA editing sites across varied biological conditions using the CADRES pipeline. Article Snippet: The Cell Culture:Article Title: Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor Article Snippet: .. Article Title: Patient-derived extracellular matrix from decellularized high-grade serous ovarian carcinoma tissues as a biocompatible support for organoid growth Article Snippet: .. The Article Title: Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 Article Snippet: .. JEG-3(ATCC HTB-36), a human choriocarcinoma cell line of human CLDN6-positive cells, Article Title: Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate Article Snippet: .. JEG-3(ATCC HTB-36), a human choriocarcinoma cell line of human CLDN6-positive cells, Article Title: 3C conjugates: a highly sensitive platform for antibody internalization assessment in ADC development Article Snippet: NCI-N87, a gastric cancer cell line (SIBCB, SCSP-534), was cultured in RPMI 1640 medium (MeilunBio, PWL015) supplemented with 10% FBS. .. OVCAR3, an |